[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337878-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337878-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-of-key-genes-and-signalling-pathways-in-clear-cell-renal-cell-carcinoma-an-integrated-bioinformatics-approach","Identification of key genes and signalling pathways in clear cell renal cell carcinoma - An integrated bioinformatics approach","","Clear cell renal cell carcinoma (ccRCC) is a common kidney cancer in which uncovering driver genes and signaling changes remains complex. This integrated study selects twelve ccRCC microarray datasets from the GEO database and performs GEO2R-based differential expression to obtain 179 common DEGs. Functional enrichment is run with ToppFun, followed by protein-protein interaction network construction in Cytoscape and MCODE clustering. Hub genes are prioritized using degree, betweenness, and closeness, with GEPIA validation in normal versus ccRCC tissues. Results show enrichment in HIF signaling and metabolic reprogramming, identifying VEGFA, CAV1, LOX, CCND1, PLG, EGF, SLC2A1, and ENO2.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-of-key-genes-and-signalling-pathways-in-clear-cell-renal-cell-carcinoma-an-integrated-bioinformatics-approach/337878/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-of-key-genes-and-signalling-pathways-in-clear-cell-renal-cell-carcinoma-an-integrated-bioinformatics-approach/337878.png","ImageObject",300,407,{"name":42,"@type":43},"Violet","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What datasets and analysis approach were used to identify genes in ccRCC?","Question",{"text":63,"@type":64},"Twelve ccRCC microarray datasets were selected from GEO and analyzed using GEO2R to identify 179 common differentially expressed genes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were hub genes determined and validated?",{"text":68,"@type":64},"A protein-protein interaction network was built in Cytoscape, clusters were detected using MCODE, and hub genes were ranked using centrality measures (degree, betweenness, closeness). GEPIA was used to validate hub gene expression in normal and ccRCC tissues.",{"name":70,"@type":61,"acceptedAnswer":71},"Which pathways were most enriched among the common DEGs?",{"text":72,"@type":64},"The common DEGs were highly enriched in hypoxia-inducible factor (HIF) signaling and metabolic reprogramming pathways.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337878,1790189371,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Cancer Biomarkers 40 (2024) 111–123 DOI 10.3233/CBM-230271  \nIOS Press  \nIdentiﬁcation of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach  \n111  \nVinoth Sa , Satheeswaran Balasubramanianb , Ekambaram Perumalb and Kirankumar Santhakumara ;􀀃 a Department of Genetic Engineering, Zebraﬁsh Genetics Laboratory, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu, India  \nb Department of Biotechnology, Molecular Toxicology Laboratory, Bharathiar University, Coimbatore, Tamil Nadu, India  \nReceived 6 July 2023 Accepted 10 January 2024  \nAbstract.  \nBACKGROUND: Clear cell Renal Cell Carcinoma (ccRCC) is one of the most prevalent types of kidney cancer. Unravelling the genes responsible for driving cellular changes and the transformation of cells in ccRCC pathogenesis is a complex process. OBJECTIVE: In this study, twelve microarray ccRCC datasets were chosen from the gene expression omnibus (GEO) database and subjected to integrated analysis.  \nMETHODS: Through GEO2R analysis, 179 common differentially expressed genes (DEGs) were identiﬁed among the datasets. The common DEGs were subjected to functional enrichment analysis using ToppFun followed by construction of protein-protein interaction network (PPIN) using Cytoscape. Clusters within the DEGs PPIN were identiﬁed using the Molecular Complex Detection (MCODE) Cytoscape plugin. To identify the hub genes, the centrality parameters degree, betweenness, and closeness scores were calculated for each DEGs in the PPIN. Additionally, Gene Expression Proﬁling Interactive Analysis (GEPIA) was utilized to validate the relative expression levels of hub genes in the normal and ccRCC tissues.  \nRESULTS: The common DEGs were highly enriched in Hypoxia-inducible factor (HIF) signalling and metabolic reprogramming pathways. VEGFA, CAV1, LOX, CCND1, PLG, EGF, SLC2A1, and ENO2 were identiﬁed as hub genes.  \nCONCLUSION: Among 8 hub genes, only the expression levels of VEGFA, LOX, CCND1, and EGF showed a unique expression pattern exclusively in ccRCC on compared to other type of cancers.  \nKeywords: Kidney cancer, hypoxia, metabolic reprogramming, hub genes, cancer biomarker  \n1. Introduction  \nRenal cell carcinoma (RCC) includes various subtypes of kidney tumours characterized by numerous genetic abnormalities. Clear cell renal cell carcinoma (ccRCC), also known as kidney renal clear cell carcinoma (KIRC) is a crucial RCC subtype that accounts for about 8 out of 10 kidney cancer diagnoses and 2–  \n􀀃 Corresponding author: Kirankumar Santhakumar, Department of Genetic Engineering, Zebraﬁsh Genetics Laboratory, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, Tamil Nadu – 603 203, India. Tel.: +91 9965965005; E-mail: kirankus@ [srmist.edu.in](srmist.edu.in).  \n3% of all cancer [1] . According to GLOBOCAN, the global cancer statistics, more than four lakh new cases are reported, causing one lakh deaths per year in kidney cancer for the year 2020 [1,2] . The ccRCC is characterized by clear cytoplasm in the malignant epithelial cells, dense alveoli, and acinar growth patterns interspersed with complex branched blood vessels [3] . The ccRCC tumour develops irrespective of age, but most cases are reported between 50 to 70 years with less than six percent of children and young adults affected [4,5] . The exact cause of ccRCC progression is unknown, but the following factors increase the risk: smoking, repeated use of painkillers, patients with other kidney diseases  \nISSN 1574-0153 􀀍c 2024 – The authors. Published by IOS Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC 4 .0) .  \n112 V. S et al. / Identiﬁcation of key genes and signalling pathways in clear cell renal cell carcinoma  \nundergoing dialysis, and major genetic predisposition conditions including gene mutations [6] .  \nThe biallelic loss of Von Hippel–Lindau","cbCailkimuBU2gQw","https://ap.wps.com/l/cbCailkimuBU2gQw","pdf",2252175,13,"English","# Abstract\n## Background, Objective, Methods, Results, Conclusion\n# Introduction\n## Disease overview and risk factors\n## Genetic drivers and signaling pathways\n## Drug resistance and need for biomarkers\n# Study rationale and aim","[{\"question\":\"What datasets and analysis approach were used to identify genes in ccRCC?\",\"answer\":\"Twelve ccRCC microarray datasets were selected from GEO and analyzed using GEO2R to identify 179 common differentially expressed genes.\"},{\"question\":\"How were hub genes determined and validated?\",\"answer\":\"A protein-protein interaction network was built in Cytoscape, clusters were detected using MCODE, and hub genes were ranked using centrality measures (degree, betweenness, closeness). GEPIA was used to validate hub gene expression in normal and ccRCC tissues.\"},{\"question\":\"Which pathways were most enriched among the common DEGs?\",\"answer\":\"The common DEGs were highly enriched in hypoxia-inducible factor (HIF) signaling and metabolic reprogramming pathways.\"}]","Identification of key genes and signalling pathways in clear cell renal cell carcinoma - An integrated bioinformatics approach | PDF",1790021022,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bcc5bd6a7b376ff32d89c9984a2c431b.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/252d3b8637447681de2d7691868592e0.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64f833281b5119ffbfeec903765ca97d.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/550d299c8de47d49518d79a5888536d3.webp",980,1385]